Long Peripheral Catheters first-line device for for Multiday IV Therapy in kids: Study
Establishment of functioning peripheral intravenous (IV) access is a vital step to provide care in the emergency and inpatient settings. A recent study suggests that Long Peripheral Catheters (LPCs) reduces catheter failure and total catheters in children and recommend the use of LPCs as the first-line device for peripheral access. The study findings were published in the journal PEDIATRICS on January 14, 2021.
Patients with a medical history of obesity, IV drug abuse (IVDA), end-stage renal disease (ESRD), and/or sickle cell disease have been shown to have Difficult Vascular Access (DVA) using the traditional technique. Once cannulated, the survival time of IV catheters is problematic, with early failure a common complication. In children, intravenous therapy (IVT) is generally administered via peripheral intravenous catheters (PIVCs) (2–6 cm in length). However, a previous study suggests that PIVCs are unreliable after 2 days. Long peripheral catheters (LPCs) (6–15 cm in length) could improve the delivery of IVT, but the data available are limited. Therefore, researchers of Melbourne, Australia, conducted a study to determine if LPCs could decrease catheter failure and the number of catheters in children receiving multiday IVT.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.